PHASE I STUDY OF CABAZITAXEL IN PEDIATRIC PATIENTS WITH RELAPSED OR REFRACTORY SOLID TUMORS: A POETIC GROUP STUDY

被引：0
|
作者：
Manley, P. [1 ]
Trippett, T. [2 ]
Smith, A. [3 ]
Macy, M. [4 ]
Leary, S. [5 ,6 ]
Boklan, J. [7 ]
Cohen, K. [8 ]
Shen, L. [9 ]
Herzog, C. [10 ]
Veyrat-Follet, C. [11 ]
Zhang, J. [12 ]
Chi, S. [1 ]
机构：
[1] Dana Farber Canc Inst, Pediat Oncol, Boston, MA 02115 USA
[2] Mem Sloan Kettering Canc Ctr, Pediat Hematol Oncol, New York, NY 10021 USA
[3] Arnold Palmer Med Ctr, Pediat Hematol Oncol, Orlando, FL USA
[4] Univ Colorado, Childrens Hosp Colorado, Pediat Hematol Oncol, Aurora, CO USA
[5] Seattle Childrens Univ Washington, Seattle, WA USA
[6] Fred Hutchinson Canc Res Ctr, Pediat Hematol Oncol, Seattle, WA 98104 USA
[7] Phoenix Childrens Hosp, Pediat Hematol Oncol, Phoenix, AZ USA
[8] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Pediat Hematol Oncol, Baltimore, MD USA
[9] Sanofi US, Sanofi Oncol, Bridgewater, MA USA
[10] Univ Texas MD Anderson Canc Ctr, Pediat Hematol Oncol, Houston, TX 77030 USA
[11] Sanofi, Drug Disposit Disposit Safety & Anim Res Dept, Vitry Sur Seine, France
[12] Sanofi, Sanofi Oncol, Cambridge, MA USA
来源：
PEDIATRIC BLOOD & CANCER | 2015年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O-049
引用
收藏
页码：S157 / S158
页数：2
相关论文
共 50 条
  • [31] Phase I clinical study of oral olaparib in pediatric patients with refractory solid tumors: study protocol
    Masatoshi Takagi
    Chitose Ogawa
    Yuki Aoki-Nogami
    Tomoko Iehara
    Eri Ishibashi
    Minoru Imai
    Tetsuro Kihara
    Kiyoshi Nobori
    Kazuhisa Hasebe
    Shuki Mizutani
    Toshimi Kimura
    Masashi Nagata
    Masato Yasuhara
    Kenichi Yoshimura
    Pariko Yorozu
    Hajime Hosoi
    Ryuji Koike
    BMC Pediatrics, 19
  • [32] A PHASE I STUDY ON CABOZANTINIB MONOTHERAPY IN PEDIATRIC PATIENTS WITH RECURRENT AND/OR REFRACTORY SOLID TUMORS (CAMEL STUDY)
    Nakajima, Miho
    Tao, Kayoko
    Kimura, Toshimi
    Ogawa, Chitose
    Arakawa, Ayumu
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [33] Phase I Dose Finding Study for Melatonin in Pediatric Oncology Patients with Relapsed Solid Tumors
    Johnston, D.
    Zupanec, S.
    Nicksy, D.
    Morgenstern, D.
    Narendran, A.
    Deyell, R.
    Samson, Y.
    Baruchel, S.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S513 - S513
  • [34] A PHASE-I TRIAL OF FAZARABINE IN REFRACTORY PEDIATRIC SOLID TUMORS - A PEDIATRIC-ONCOLOGY-GROUP STUDY
    BERNSTEIN, ML
    WHITEHEAD, VM
    GRIER, H
    DUBOWY, R
    LAND, V
    DEVINE, S
    MURPHY, S
    KUNG, F
    INVESTIGATIONAL NEW DRUGS, 1993, 11 (04) : 309 - 312
  • [35] A phase I study of panobinostat in pediatric patients with refractory solid tumors, including CNS tumors.
    Wood, Paul James
    Strong, Robyn
    McArthur, Grant A.
    Michael, Michael
    Algar, Elizabeth
    Muscat, Andrea
    Rigby, Lin
    Ashley, David M.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [36] A phase I trial and pharmacolkinetic study of gefitinib in pediatric patients with refractory solid tumors: A Children's Oncology Group Study.
    Daw, NC
    Furman, WL
    Stewart, CF
    Iacono, LC
    Krailo, M
    Bernstein, M
    Dancey, JE
    Blaney, S
    Adamson, PC
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 804S - 804S
  • [37] A phase I study of oxaliplatin (OXA) and irinotecan (IRN) in pediatric patients with refractory solid tumors: A Children's Oncology Group study
    McGregor, L. M.
    Spunt, S. L.
    Furman, W. L.
    Stewart, C. F.
    Krailo, M. D.
    Speights, R.
    Houghton, P. J.
    Ivy, S. P.
    Blaney, S. M.
    Adamson, P. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [38] Phase I trial of tirapazamine and cyclophosphamide in children with refractory solid tumors: A pediatric oncology group study
    Aquino, VM
    Weitman, SD
    Winick, NJ
    Blaney, S
    Furman, WL
    Kepner, JL
    Bonate, P
    Krailo, M
    Qu, WC
    Bernstein, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (08) : 1413 - 1419
  • [39] Development of Phase I Clinical Study of Oral Olaparib in Pediatric Patients with Refractory Solid Tumors
    Takagi, Masatoshi
    Takita, Junko
    Ogawa, Chitose
    Iehara, Tomoko
    Hosoi, Hajime
    PEDIATRIC BLOOD & CANCER, 2020, 67
  • [40] A phase I study of gefitinib and irinotecan (IRN) in pediatric patients with refractory solid tumors.
    Furman, WL
    Daw, NC
    Crews, KR
    Stewart, CF
    McCarville, B
    Santana, VM
    Hawkins, D
    Rodriguez-Galindo, C
    Navid, F
    Houghton, PJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 804S - 804S
12345